Sweetch key facts
as of Oct 2026- Developer of a hyper-personalized engagement platform intended to improve clinical outcomes for people with chronic conditions.
- Sweetch is valued at approximately $47.0M as of Oct 2026 (last reported valuation).
- It has raised $37.2M; the latest was Later Stage VC in May 2025.
- Notable investors include OurCrowd, Entrée Capital, Decacorn Capital, Noaber Ventures, FinTLV Ventures — 18 tracked in total.
- Status: Privately Held (backing).
Sweetch's last reported valuation, Jul 2021. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch Sweetch: the Monday email on marks, rounds and moves
Sweetch funding rounds
No funding rounds for Sweetch are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Sweetch
18+Membership and data by Private Market View
Sweetch valuation
Sweetch's last reported valuation was $47 million in Jul 2021. No priced round, secondary trade or fund mark has surfaced since.
Sweetch investors
18 investors are on record for Sweetch, including OurCrowd, Entrée Capital, Decacorn Capital and Noaber Ventures.
About Sweetch
Developer of a hyper-personalized engagement platform intended to improve clinical outcomes for people with chronic conditions. The company's platform allows individuals to achieve their health goals with hyper-personalized recommendations in the right time, tone, and real-world context every step of the way throughout their health journey, enabling pharmaceutical companies, device manufacturers, payers, and healthcare providers to build continuous relationships and engage with every individual patient with chronic conditions, at scale.
- Sector
- Healthcare
- HQ
- Ramat Gan, Israel
- Founded
- 2013
- Employees
- 49
- Website
- sweetch.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.